Citigroup Inc. Raises Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Citigroup Inc. increased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 20.1% during the third quarter, according to its most recent filing with the SEC. The fund owned 351,529 shares of the real estate investment trust's stock after buying an additional 58,950 shares during the quarter. Citigroup Inc. owned 0.13% of Omega Healthcare Investors worth $14,307,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Daiwa Securities Group Inc. lifted its holdings in Omega Healthcare Investors by 1,030.8% during the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust's stock valued at $32,384,000 after purchasing an additional 861,907 shares during the last quarter. Marshall Wace LLP purchased a new stake in Omega Healthcare Investors during the second quarter valued at about $20,962,000. Dimensional Fund Advisors LP lifted its holdings in Omega Healthcare Investors by 7.9% during the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock valued at $127,831,000 after purchasing an additional 272,299 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Omega Healthcare Investors by 6.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust's stock valued at $155,893,000 after purchasing an additional 240,006 shares during the last quarter. Finally, Sei Investments Co. lifted its holdings in Omega Healthcare Investors by 150.8% during the second quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust's stock valued at $10,233,000 after purchasing an additional 179,623 shares during the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

OHI has been the topic of several recent research reports. Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They set a "buy" rating and a $45.00 price objective on the stock. Wells Fargo & Company reiterated an "overweight" rating and set a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Scotiabank upped their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a research report on Monday, August 26th. Royal Bank of Canada upped their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a research report on Monday, November 11th. Finally, BNP Paribas upgraded Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price target on the stock in a research report on Thursday, October 31st. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $40.00.

Insider Buying and Selling

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the company's stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company's stock, valued at $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the company's stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

Omega Healthcare Investors Price Performance

Shares of OHI stock traded down $0.10 during trading on Thursday, hitting $40.67. The company had a trading volume of 2,137,387 shares, compared to its average volume of 1,689,291. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The stock's 50-day moving average is $40.61 and its two-hundred day moving average is $37.24. The stock has a market capitalization of $10.98 billion, a price-to-earnings ratio of 29.90, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $44.42.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.59%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.